应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
03347 泰格医药
未开盘 08-13 16:08:14
41.780
+0.480
+1.16%
最高
42.400
最低
40.700
成交量
213.41万
今开
41.400
昨收
41.300
日振幅
4.12%
总市值
359.73亿
流通市值
51.44亿
总股本
8.61亿
成交额
8,960万
换手率
1.73%
流通股本
1.23亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
免责声明:香港交易所资讯服务有限公司、其控股公司及/或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度,但不能保证其绝对准确和可靠,且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任(不管是否侵权法下的责任或合约责任又或其它责任)
资讯
新帖
简况
泰格医药:截至目前,公司实际控制人尚未接到该事项的进一步通知
证券之星 · 08-11 16:33
泰格医药:截至目前,公司实际控制人尚未接到该事项的进一步通知
8月7日泰格医药涨9.51%,兴全商业模式LOF基金重仓该股
证券之星 · 08-07
8月7日泰格医药涨9.51%,兴全商业模式LOF基金重仓该股
医药股强势走强 再鼎医药(09688)涨13.97%、药明生物(02269)涨5.41%
金吾财讯 · 08-07
医药股强势走强 再鼎医药(09688)涨13.97%、药明生物(02269)涨5.41%
药明康德(02359)中期业绩提振医药外包概念股 凯莱英(06821)涨7.98%
金吾财讯 · 08-04
药明康德(02359)中期业绩提振医药外包概念股 凯莱英(06821)涨7.98%
港股开盘 | 恒指高开0.31% 医药CXO板块走强 药明康德(02359)涨近10%、中际旭创(03308)涨超9%
智通财经 · 08-04
港股开盘 | 恒指高开0.31% 医药CXO板块走强 药明康德(02359)涨近10%、中际旭创(03308)涨超9%
泰格医药(300347)披露回购公司股份进展公告,8月3日股价下跌0.72%
证券之星 · 08-03
泰格医药(300347)披露回购公司股份进展公告,8月3日股价下跌0.72%
泰格医药(03347)披露回购进展:已耗资约8.24亿元回购2096.35万股
公告速递 · 08-03
泰格医药(03347)披露回购进展:已耗资约8.24亿元回购2096.35万股
泰格医药(03347):截至7月末累计回购2096.3万股A股
智通财经 · 08-03
泰格医药(03347):截至7月末累计回购2096.3万股A股
泰格医药2026年7月股份变动月报表,股本维持稳定
公告速递 · 08-03
泰格医药2026年7月股份变动月报表,股本维持稳定
泰格医药:将于8月29日披露截至2026年6月30日公司股东人数
证券之星 · 08-03
泰格医药:将于8月29日披露截至2026年6月30日公司股东人数
医药外包概念整体回暖 昭衍新药(06127)涨4.51%、康龙化成(03759)涨3.10%
金吾财讯 · 07-31
医药外包概念整体回暖 昭衍新药(06127)涨4.51%、康龙化成(03759)涨3.10%
7月29日泰格医药涨5.66%,兴全商业模式LOF基金重仓该股
证券之星 · 07-29
7月29日泰格医药涨5.66%,兴全商业模式LOF基金重仓该股
医药外包概念全线扬升 昭衍新药(06127)涨7.93% 机构指CXO景气进入中报业绩兑现期
金吾财讯 · 07-27
医药外包概念全线扬升 昭衍新药(06127)涨7.93% 机构指CXO景气进入中报业绩兑现期
小摩增持泰格医药(03347)约56.66万股 每股作价约36.84港元
智通财经 · 07-23
小摩增持泰格医药(03347)约56.66万股 每股作价约36.84港元
港股直击 | 生物医药股走强,康方生物涨近7%,荣昌生物涨超4%,泰格医药、诺诚健华涨近3%
老虎资讯综合 · 07-22
港股直击 | 生物医药股走强,康方生物涨近7%,荣昌生物涨超4%,泰格医药、诺诚健华涨近3%
乔迁2026年二季度表现,兴全商业模式LOF基金季度涨幅25.33%
证券之星 · 07-21
乔迁2026年二季度表现,兴全商业模式LOF基金季度涨幅25.33%
郭锐2026年二季度表现,招商丰盈积极配置混合A基金季度涨幅11.42%
证券之星 · 07-21
郭锐2026年二季度表现,招商丰盈积极配置混合A基金季度涨幅11.42%
张迎军2026年二季度表现,博道嘉瑞混合A基金季度涨幅37.8%
证券之星 · 07-21
张迎军2026年二季度表现,博道嘉瑞混合A基金季度涨幅37.8%
Norges Bank减持泰格医药(03347.HK)51.49万股 每股作价39.7061港元
智通财经 · 07-20
Norges Bank减持泰格医药(03347.HK)51.49万股 每股作价39.7061港元
创新药连续大涨,这次真的不一样了吗?
华尔街见闻 · 07-16
创新药连续大涨,这次真的不一样了吗?
加载更多
公司概况
公司名称:
泰格医药
所属市场:
SEHK
上市日期:
--
主营业务:
杭州泰格医药科技股份有限公司是一家主要从事为新药研发提供临床试验全过程专业服务的中国公司。该公司提供服务主要包括临床试验技术服务和临床试验相关及实验室服务。临床试验技术服务提供创新药物、仿制药及医疗器械临床试验运营服务以及与临床试验直接相关的配套服务,包括临床运营、临床药理、注册与法规事务、科学事务等服务。临床试验相关及实验室服务提供在药物开发过程中的相关及实验室服务,包括数据管理及统计分析、临床试验现场管理、受试者招募、医学影像以及实验室等服务。
发行价格:
--
{"stockData":{"symbol":"03347","market":"HK","secType":"STK","nameCN":"泰格医药","latestPrice":41.78,"timestamp":1786608494006,"preClose":41.3,"halted":0,"volume":2134058,"delay":0,"changeRate":0.011622276029055786,"floatShares":123124800,"shares":861000000,"eps":1.2099383210132306,"marketStatus":"未开盘","change":0.48,"latestTime":"08-13 16:08:14","open":41.4,"high":42.4,"low":40.7,"amount":89600074,"amplitude":0.041162,"askPrice":41.78,"askSize":2600,"bidPrice":41.52,"bidSize":100,"shortable":3,"etf":0,"ttmEps":1.0653157895851972,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786671000000},"marketStatusCode":0,"adr":0,"listingDate":1596729600000,"exchange":"SEHK","adjPreClose":41.3,"dividendRate":0.003485,"openAndCloseTimeList":[[1786584600000,1786593600000],[1786597200000,1786608000000]],"volumeRatio":1.048462,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"300347","market":"SZ","secType":"STK","nameCN":"泰格医药","latestPrice":55.32,"timestamp":1786604400000,"preClose":53.7,"halted":0,"volume":29173200,"delay":0,"premium":"-35.08"}},"requestUrl":"/m/hq/s/03347","defaultTab":"news","newsList":[{"id":"2658399311","title":"泰格医药:截至目前,公司实际控制人尚未接到该事项的进一步通知","url":"https://stock-news.laohu8.com/highlight/detail?id=2658399311","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658399311?lang=zh_cn&edition=full","pubTime":"2026-08-11 16:33","pubTimestamp":1786437190,"startTime":"0","endTime":"0","summary":"证券之星消息,泰格医药(300347)08月11日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好,请问公司被调查的事项,进展到哪一步了?什么时候有个大的方向。泰格医药回复:投资者您好,截至目前,公司实际控制人尚未接到该事项的进一步通知。谢谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。相关 ETF责任编辑:刘浩然","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100025940.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1146622755.USD","300347","BK1583","03347","BK0216","BK0174","BK0028","BK1576","BK1141","BK0077","LU1820825898.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657616131","title":"8月7日泰格医药涨9.51%,兴全商业模式LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2657616131","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657616131?lang=zh_cn&edition=full","pubTime":"2026-08-07 16:48","pubTimestamp":1786092506,"startTime":"0","endTime":"0","summary":"证券之星消息,8月7日泰格医药涨9.51%,收盘报54.35元,换手率5.83%,成交量33.01万手,成交额17.29亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共85家,其中持有数量最多的公募基金为兴证全球基金的兴全商业模式LOF。兴全商业模式LOF的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080700028189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1820825898.SGD","BK1583","LU1146622755.USD","300347","BK0077","03347","BK1141","BK1576","BK0028","BK0216","BK0174"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657660793","title":"医药股强势走强 再鼎医药(09688)涨13.97%、药明生物(02269)涨5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2657660793","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657660793?lang=zh_cn&edition=full","pubTime":"2026-08-07 10:06","pubTimestamp":1786068387,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药股强势走强,再鼎医药 涨13.97%,药明生物涨5.41%,药明合联涨4.78%,药明康德涨4.73%,百济神州涨3.66%,荣昌生物涨2.33%,泰格医药涨2.07%。。国信证券表示,2026年版国家基本药物目录近期正式发布,这是目录时隔8年再次进行系统调整。新版目录结合疾病谱变化和临床用药需求,进一步补充慢性病、儿童、专科疾病及中医药优势病种用药,并对剂型、规格进行优化,提升药品在不同人群和医疗场景中的适用性。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/Y2E2NzVmYjg0MWU1MjU0NDY3MDY2MjI=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987694","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0516422440.USD","LU0052750758.USD","LU0359202008.SGD","159938","LU0181495838.USD","BK4531","LU0588546209.SGD","02359","02268","LU0039217434.USD","LU2039709279.SGD","LU0856984785.SGD","LU1880383366.USD","LU1303224171.USD","BK4585","LU0140636845.USD","LU2328871848.SGD","LU2488822045.USD","06160","IE00B0JY6N72.USD","LU2242644610.SGD","LU0456846285.SGD","02269","LU1770034418.SGD","LU2045819591.USD","LU0348766576.USD","09995","BK1589","LU0348767384.USD","09939","LU0516422952.EUR","03347","BK1515","LU0043850808.USD","LU1794554557.SGD","BK1574","ZLAB","LU0051755006.USD","LU0516423174.USD","09688","LU0572944931.SGD","KURE","LU0823426308.USD","LU1720050803.USD","BK1583","SG9999002562.SGD","LU0348735423.USD","BK4526","LU0326950275.SGD","LU0327786744.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656863415","title":"药明康德(02359)中期业绩提振医药外包概念股 凯莱英(06821)涨7.98%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656863415","media":"金吾财讯","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656863415?lang=zh_cn&edition=full","pubTime":"2026-08-04 09:36","pubTimestamp":1785807412,"startTime":"0","endTime":"0","summary":"金吾财讯 | 药明康德 中期业绩强劲,推动股价大涨逾14%,同步提振医药外包概念股,凯莱英涨7.98%,康龙化成涨7.58%,泰格医药涨5.62%,金斯瑞生物科技涨6.01%,药明生物涨4.95%,昭衍新药涨4.93%,维亚生物涨1.96%。据药明康德公告,上半年公司实现营业收入288.97亿元,同比增长38.93%;归属于上市公司股东的净利润110.8亿元,同比增长29.43%;扣非净利润105.72亿元,同比增长89.39%。公司计划上半年向全体股东每10股派发现金红利5.10元。","market":"nz","thumbnail":"https://static.szfiu.com/news/20250110/MDc3ODQ0ZjRmZjY3NDY3NWE2ZmExZWEzMjkyYmRjMmI4NjI3MTMyNDA2NzU1.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250110/MDc3ODQ0ZjRmZjY3NDY3NWE2ZmExZWEzMjkyYmRjMmI4NjI3MTMyNDA2NzU1.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987415","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1046422090.SGD","BK1583","LU0359202008.SGD","01548","HK0000320264.USD","LU2242644610.SGD","LU2045819591.USD","02359","03347","03759","LU1303224171.USD","LU1808992512.USD","LU0320764599.SGD","LU2495084118.USD","BK1589","IE00B5MMRT66.SGD","BK0239","LU0823426308.USD","KURE","06821","LU0516422440.USD","LU1251922891.USD","LU0307460666.USD","IE00BPRC5H50.USD","LU1997245094.SGD","LU0348766576.USD","LU0856984785.SGD","159938","603259","01873","BK1191","HK0000320223.HKD","LU0456842615.SGD","HK0000306685.HKD","09939","LU1688375341.USD","LU0700851271.USD","02269","LU0348767384.USD","LU0611395673.USD","LU2488822045.USD","BK1515","LU0979878070.USD","SG9999002562.SGD","002821","BK1610","BK1576","LU0181495838.USD","06127","LU0039217434.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656816586","title":"港股开盘 | 恒指高开0.31% 医药CXO板块走强 药明康德(02359)涨近10%、中际旭创(03308)涨超9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656816586","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656816586?lang=zh_cn&edition=full","pubTime":"2026-08-04 09:34","pubTimestamp":1785807258,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,8月4日,恒生指数高开0.31%,报26090.98点;恒生科技指数涨0.30%,报4890.34点。医药CXO板块大幅走强,药明康德涨近10%,药明生物涨超3%,昭衍新药涨近6%,凯莱英涨超5%,泰格医药涨近4%。药明康德此前披露半年报,上半年营收288.97亿元同比增长38.93%,并全面上调全年业绩指引。光通信板块活跃,中际旭创涨超9%。云计算及AI应用板块走高,金山云涨超5%。受隔夜美股科技板块走强带动,港股今日延续高开。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475568.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["09067","LU0417516902.SGD","LU0181495838.USD","LU0823426308.USD","300347","BK1141","03033","BK1122","LU0140636845.USD","LU0456827905.SGD","09088","02269","LU1794554557.SGD","BK1610","BK1583","03067","BK1149","82800","02837","03037","LU1242518931.SGD","BK1249","LU0823426480.USD","002821","06127","BK1521","LU2039709279.SGD","LU1720050803.USD","LU2125910500.SGD","513600","LU1046422090.SGD","LU1688375341.USD","HSTECH","LU0307460666.USD","LU0348825331.USD","02359","300308","07226","LU0052750758.USD","603259","HHImain","SG9999002463.SGD","LU0516422952.EUR","LU0516423091.SGD","LU2242644610.SGD","LU0320764599.SGD","LU0456846285.SGD","09115","LU0043850808.USD","LU0359202008.SGD","LU0359201612.USD","LU0708995583.HKD","LU0326950275.SGD","03417","03347","LU0327786744.USD","BK1191","03115","LU0348766576.USD","LU0417516738.SGD","06821","SG9999002562.SGD","03308","03088","LU1242518857.USD","LU0588546209.SGD","MCHmain","603127","03032","LU0819121731.USD","LU3063872942.SGD","LU0051755006.USD","LU0572944931.SGD","HSI","07200","03423","BK1576","02800","83115","LU0039217434.USD","LU0348735423.USD","BK1589","IE00B0JY6N72.USD","07552","KURE","LU0979878070.USD","BK1533","03419","LU0516422366.SGD","02833","LU1880383366.USD","LU2045819591.USD","07300","LU0856984785.SGD","WXXWY","LU0348767384.USD","07500","LU0516422440.USD","LU0516423174.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656372401","title":"泰格医药(300347)披露回购公司股份进展公告,8月3日股价下跌0.72%","url":"https://stock-news.laohu8.com/highlight/detail?id=2656372401","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656372401?lang=zh_cn&edition=full","pubTime":"2026-08-03 22:07","pubTimestamp":1785766049,"startTime":"0","endTime":"0","summary":"截至2026年8月3日收盘,泰格医药报收于49.63元,较前一交易日下跌0.72%,最新总市值为427.33亿元。该股当日开盘49.88元,最高50.51元,最低49.05元,成交额达5.53亿元,换手率为1.96%。公司于2026年8月3日披露《关于回购公司股份的进展公告》。公告显示,杭州泰格医药科技股份有限公司于2026年5月13日及6月9日召开董事会及股东大会,审议通过回购公司股份方案。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300036714.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1146622755.USD","BK0174","BK0077","300347","BK1141","03347","BK0216","LU1820825898.SGD","BK1576","BK0028","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185761539","title":"泰格医药(03347)披露回购进展:已耗资约8.24亿元回购2096.35万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1185761539","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1185761539?lang=zh_cn&edition=full","pubTime":"2026-08-03 19:21","pubTimestamp":1785756107,"startTime":"0","endTime":"0","summary":"2026年8月3日,杭州泰格医药科技股份有限公司发布《关于回购公司股份的进展公告》,披露截至2026年7月31日的回购最新情况。截至2026年7月31日,公司已通过回购专用证券账户以集中竞价交易方式累计回购股份20,963,478股,约合2096.35万股,占公司目前总股本的2.4347%,占A股总股本的2.8410%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656375395","title":"泰格医药(03347):截至7月末累计回购2096.3万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2656375395","media":"智通财经","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656375395?lang=zh_cn&edition=full","pubTime":"2026-08-03 19:19","pubTimestamp":1785755947,"startTime":"0","endTime":"0","summary":"智通财经APP讯,泰格医药(03347)发布公告,截至2026年7月31日,公司通过股份回购专用证券账户以集中竞价交易方式回购公司股份2096.3万股,占公司目前总股本的2.4347%,占公司目前A股总股本的2.8410%。最高成交价为42.78元/股,最低成交价为38.22元/股,成交总金额为8.24亿元(不含交易费用)。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1475393.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0174","LU1146622755.USD","BK0077","BK1141","399300","BK1583","BK0216","BK1576","03347","LU1820825898.SGD","159982","300347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168194063","title":"泰格医药2026年7月股份变动月报表,股本维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1168194063","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1168194063?lang=zh_cn&edition=full","pubTime":"2026-08-03 16:51","pubTimestamp":1785747092,"startTime":"0","endTime":"0","summary":"杭州泰格医药科技股份有限公司于2026年8月3日发布2026年7月股份变动月报表。报告披露,截至2026年7月31日,公司法定/注册股本总额为人民币861,026,050元,与上月末保持不变。在已发行股票方面,公司A股已发行股份数为711,053,992股,库存股为26,847,258股,总数为737,901,250股,较上月未发生变动;H股已发行股份数为123,124,800股,库存股为0股,总数为123,124,800股,同样保持稳定。公司此前于2024年至2026年期间基于多次回购累积获得26,847,258股A股库存股份,此次月度报告期间无新进展。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656325019","title":"泰格医药:将于8月29日披露截至2026年6月30日公司股东人数","url":"https://stock-news.laohu8.com/highlight/detail?id=2656325019","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2656325019?lang=zh_cn&edition=full","pubTime":"2026-08-03 15:03","pubTimestamp":1785740599,"startTime":"0","endTime":"0","summary":"证券之星消息,泰格医药(300347)08月03日在投资者关系平台上答复投资者关心的问题。投资者提问:董秘您好:为了维护股价,希望公司能及时公布股东人数,比如截止7月25日股东人数是多少?泰格医药回复:投资者您好,公司将于8月29日披露的《2026年半年度报告》中相关章节公告截至2026年6月30日公司股东人数,请您关注公司于巨潮资讯网的公告。谢谢您的关注!本文数据来源于深圳证券交易所互动易,仅供参考不构成投资建议。相关 ETF责任编辑:陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080300013729.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300347","BK1141","BK0077","BK0216","BK1583","BK1576","03347","LU1820825898.SGD","BK0174","LU1146622755.USD","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655333030","title":"医药外包概念整体回暖 昭衍新药(06127)涨4.51%、康龙化成(03759)涨3.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655333030","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655333030?lang=zh_cn&edition=full","pubTime":"2026-07-31 10:18","pubTimestamp":1785464310,"startTime":"0","endTime":"0","summary":"金吾财讯 | 港股医药外包概念整体回暖,截止发稿,昭衍新药 涨4.51%,康龙化成涨3.10%,金斯瑞生物科技涨2.97%,凯莱英涨2.77%,药明生物涨2.75%,药明康德涨2.60%,泰格医药涨1.39%。26年至今国内创新药行业的长期结构性机会持续兑现,国内投融资持续改善,新药物形式赛道持续火热并进一步放量,该机构认为26年国内CRO/CDMO行业的新签订单及业绩会加速增长,带动CXO产业链进入新一轮发展阶段。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250109/MjdmY2Y4OTEwODUyNTc5NjI3Mg==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1987205","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999002463.SGD","LU0327786744.USD","LU1880383366.USD","LU0140636845.USD","LU1046422090.SGD","09939","LU0823426308.USD","HK0000306685.HKD","LU3063872942.SGD","LU0348766576.USD","LU0348825331.USD","300759","LU0516422366.SGD","LU1720050803.USD","LU0359202008.SGD","BK1141","LU0516423091.SGD","02359","LU0823426480.USD","LU0320764599.SGD","LU2045819591.USD","01548","LU0708995583.HKD","LU0181495838.USD","LU0051755006.USD","06821","KURE","LU0516422440.USD","LU0307460666.USD","LU0417516738.SGD","BK1574","LU0348735423.USD","03759","BK1589","LU0819121731.USD","HK0000306701.USD","159938","03347","BK1191","06127","BK1521","LU0588546209.SGD","LU0456827905.SGD","LU1242518931.SGD","02269","LU1242518857.USD","BK1610","LU0359201612.USD","603127","LU1794554557.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655586852","title":"7月29日泰格医药涨5.66%,兴全商业模式LOF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2655586852","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2655586852?lang=zh_cn&edition=full","pubTime":"2026-07-29 16:44","pubTimestamp":1785314693,"startTime":"0","endTime":"0","summary":"证券之星消息,7月29日泰格医药涨5.66%,收盘报50.78元,换手率4.1%,成交量23.21万手,成交额11.63亿元。根据2026基金半年报公募基金重仓股数据,重仓该股的公募基金共85家,其中持有数量最多的公募基金为兴证全球基金的兴全商业模式LOF。兴全商业模式LOF的前十大重仓股如下:以上内容为证券之星据公开信息整理,仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072900027493.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["03347","BK1141","BK1576","LU1146622755.USD","BK0216","BK0174","LU1820825898.SGD","BK0028","BK1583","BK0077","300347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654095486","title":"医药外包概念全线扬升 昭衍新药(06127)涨7.93% 机构指CXO景气进入中报业绩兑现期","url":"https://stock-news.laohu8.com/highlight/detail?id=2654095486","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2654095486?lang=zh_cn&edition=full","pubTime":"2026-07-27 10:17","pubTimestamp":1785118673,"startTime":"0","endTime":"0","summary":"消息面上,开源证券新近研究指出,7月以来,康龙化成、昭衍新药、美迪西和药康生物先后发布2026年H1业绩预增公告,从早研到临床前研究,CXO景气周期已逐步进入利润表兑现期。根据医药魔方,2026H1全球创新药一级市场共发生505起融资事件,同比增长6.1%,融资金额达到267.5亿美元,同比增长58.5%。2026H1中国相关交易数量及金额涨势迅猛,总金额达997亿美元。从6月初至今,CXO板块在业绩和订单的支撑下,率先于创新药反弹。","market":"other","thumbnail":"https://static.szfiu.com/news/20241108/NmNiNTg2NTUyNjE5NjAwNw==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/NmNiNTg2NTUyNjE5NjAwNw==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1986787","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0043850808.USD","LU1242518931.SGD","LU0348767384.USD","CXO","BK1610","LU0348735423.USD","LU0823426308.USD","06821","06127","LU0417516738.SGD","603127","LU2242644610.SGD","01873","BK1589","03759","03347","KURE","159938","BK0216","01548","BK1574","HK0000320264.USD","LU0823426480.USD","LU3063872942.SGD","LU0588546209.SGD","02269","WX","LU2125910500.SGD","BK1161","LU1242518857.USD","LU0307460666.USD","LU0327786744.USD","LU0140636845.USD","LU0039217434.USD","LU0856984785.SGD","BK1583","LU0516423174.USD","LU1046422090.SGD","LU2039709279.SGD","BK1141","LU1880383366.USD","LU0516422440.USD","SG9999002562.SGD","09939","HK0000306685.HKD","BK1191","02359","LU0516422952.EUR","LU0359201612.USD","LU0348766576.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653744779","title":"小摩增持泰格医药(03347)约56.66万股 每股作价约36.84港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2653744779","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653744779?lang=zh_cn&edition=full","pubTime":"2026-07-23 19:20","pubTimestamp":1784805612,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,香港联交所最新资料显示,7月17日,小摩增持泰格医药(03347)56.6578万股,每股作价36.8414港元,总金额约为2087.35万港元。增持后最新持股数目约为2133.69万股,最新持股比例为17.32%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1471552.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["JPX","JPO","LU1551013342.USD","LU1244550494.USD","LU0943347566.SGD","LU2430703095.HKD","TFNS","BK4534","IYF","LU1244550221.USD","LU2237443465.HKD","TRUF","LU1720051108.HKD","UYG","JPMO","LU1116320737.USD","LU0267386448.USD","LU0187121727.USD","LU1116320901.HKD","LU0689472784.USD","LU1988902786.USD","IYG","300347","LU0345769631.USD","LU2023250504.SGD","LU2381873111.SGD","EWH","LU1894683348.USD","FNCL","FTXO","03347","LU0820562030.AUD","LU0964807845.USD","IE000M9KFDE8.USD","LU0265550359.USD","VFH","IE00BDRTCR15.USD","KBWB","LU1496350171.SGD","IE00BKDWB100.SGD","LU2237443895.HKD","LU0496365809.HKD","BK1576","LU0320765646.SGD","IE00BJLML261.HKD","XLF","IXG","LU0203345920.USD","LU0170899867.USD","LU0345769128.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145405224","title":"港股直击 | 生物医药股走强,康方生物涨近7%,荣昌生物涨超4%,泰格医药、诺诚健华涨近3%","url":"https://stock-news.laohu8.com/highlight/detail?id=1145405224","media":"老虎资讯综合","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1145405224?lang=zh_cn&edition=full","pubTime":"2026-07-22 10:11","pubTimestamp":1784686287,"startTime":"0","endTime":"0","summary":"7月22日,港股生物医药股走强,康方生物涨近7%,荣昌生物涨超4%,泰格医药、诺诚健华涨近3%,复宏汉霖、药明康德、君实生物涨超2%。消息面上,美国总统特朗普当地时间7月21日在社交媒体发文表示,自2026.8.1起,所有进口到美国的仿制药将在未来两年内继续适用零关税。两年期满后,相关产品将被征收100%的关税,期限为一年。此后,关税将进一步提高至200%。","market":"hk","thumbnail":"https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股直击 | 生物医药股走强,康方生物涨近7%,荣昌生物涨超4%,泰格医药、诺诚健华涨近3%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03347","02696","09969","02359","09926","01877","09995"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653201360","title":"乔迁2026年二季度表现,兴全商业模式LOF基金季度涨幅25.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653201360","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653201360?lang=zh_cn&edition=full","pubTime":"2026-07-21 23:54","pubTimestamp":1784649284,"startTime":"0","endTime":"0","summary":"证券之星消息,截止2026年二季度末,基金经理乔迁旗下共管理3只基金,本季度表现最佳的为兴全商业模式LOF,季度净值涨25.33%。期间重仓股调仓次数共有73次,其中盈利次数为42次,胜率为57.53%;翻倍级别收益有2次,翻倍率为2.74%。持有期间的估算收益率为615.76%,持有期间隆基股份在2018年到2020年的年报归属净利润增幅达234.34%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100046112.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK1141","03347","BK1576"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653493209","title":"郭锐2026年二季度表现,招商丰盈积极配置混合A基金季度涨幅11.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653493209","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653493209?lang=zh_cn&edition=full","pubTime":"2026-07-21 23:41","pubTimestamp":1784648462,"startTime":"0","endTime":"0","summary":"证券之星消息,截止2026年二季度末,基金经理郭锐旗下共管理12只基金,本季度表现最佳的为招商丰盈积极配置混合A,季度净值涨11.42%。持有期间的估算收益率为358%,持有期间泰格医药在2019年到2021年的年报归属净利润增幅达241.5%。持有期间的估算收益率为-65.71%,持有期间东方雨虹在2022年到2024年的年报营业总收入降幅为10.12%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100045920.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK1576","03347","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653209123","title":"张迎军2026年二季度表现,博道嘉瑞混合A基金季度涨幅37.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2653209123","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2653209123?lang=zh_cn&edition=full","pubTime":"2026-07-21 23:34","pubTimestamp":1784648076,"startTime":"0","endTime":"0","summary":"证券之星消息,截止2026年二季度末,基金经理张迎军旗下共管理8只基金,本季度表现最佳的为博道嘉瑞混合A,季度净值涨37.8%。张迎军在担任博道嘉泰回报混合基金经理的任职期间累计任职回报144.48%,平均年化收益率为14.52%。持有期间的估算收益率为93.07%,持有期间泰格医药在2020年到2021年的年报归属净利润增幅达64.26%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026072100045831.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1583","BK1576","BK1141","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652704290","title":"Norges Bank减持泰格医药(03347.HK)51.49万股 每股作价39.7061港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2652704290","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2652704290?lang=zh_cn&edition=full","pubTime":"2026-07-20 19:30","pubTimestamp":1784547058,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=ganggu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK1576","BK1583","BK1141","03347"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651341039","title":"创新药连续大涨,这次真的不一样了吗?","url":"https://stock-news.laohu8.com/highlight/detail?id=2651341039","media":"华尔街见闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2651341039?lang=zh_cn&edition=full","pubTime":"2026-07-16 17:05","pubTimestamp":1784192720,"startTime":"0","endTime":"0","summary":"政策上,医保初审通过率创新高,定价机制优化,并建立“医保+商保”双层支付体系;产业上,上半年BD交易总额达1100亿美元,国际竞争力显著提升;资金面上,内外资持续回流。行业正从“讲故事”转向盈利兑现,国金证券认为,2027年有望成为中国创新药海外商业化集中兑现的重要节点。","market":"hk","thumbnail":"https://static.tigerbbs.com/8daedf52c02cecfd417dcbd813afb3fa","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/8daedf52c02cecfd417dcbd813afb3fa"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3777107","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06618","02269","02359","IBBQ","06996","03347","09966","09995","09688","BK1574","159992","02137","01672","06978","06606","02268","BK1161","03759","MEDX","00241","06622","01801","09606"],"isVideo":false,"video":null,"gpt_icon":1}],"profile":{"websiteUrl":"http://www.tigermed.net","stockEarnings":[{"period":"1week","weight":0.1082},{"period":"1month","weight":0.1094},{"period":"3month","weight":0.1725},{"period":"6month","weight":-0.1441},{"period":"1year","weight":-0.2457},{"period":"ytd","weight":-0.0133}],"compareEarnings":[{"period":"1week","weight":-0.0052},{"period":"1month","weight":0.0434},{"period":"3month","weight":-0.0218},{"period":"6month","weight":-0.0441},{"period":"1year","weight":-0.0085},{"period":"ytd","weight":-0.0091}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"杭州泰格医药科技股份有限公司是一家主要从事为新药研发提供临床试验全过程专业服务的中国公司。该公司提供服务主要包括临床试验技术服务和临床试验相关及实验室服务。临床试验技术服务提供创新药物、仿制药及医疗器械临床试验运营服务以及与临床试验直接相关的配套服务,包括临床运营、临床药理、注册与法规事务、科学事务等服务。临床试验相关及实验室服务提供在药物开发过程中的相关及实验室服务,包括数据管理及统计分析、临床试验现场管理、受试者招募、医学影像以及实验室等服务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.032258},{"month":2,"riseRate":0.5,"avgChangeRate":0.003409},{"month":3,"riseRate":0.5,"avgChangeRate":-0.032695},{"month":4,"riseRate":0.166667,"avgChangeRate":-0.051086},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.017912},{"month":6,"riseRate":0.666667,"avgChangeRate":0.042051},{"month":7,"riseRate":0.666667,"avgChangeRate":0.080461},{"month":8,"riseRate":0.166667,"avgChangeRate":-0.058608},{"month":9,"riseRate":0.333333,"avgChangeRate":0.032062},{"month":10,"riseRate":0.5,"avgChangeRate":-0.025938},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.001369},{"month":12,"riseRate":0.5,"avgChangeRate":0.041242}],"exchange":"SEHK","name":"泰格医药","nameEN":"TIGERMED"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供泰格医药(03347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"泰格医药,03347,泰格医药股票,泰格医药股票老虎,泰格医药股票老虎国际,泰格医药行情,泰格医药股票行情,泰格医药股价,泰格医药股市,泰格医药股票价格,泰格医药股票交易,泰格医药股票购买,泰格医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"泰格医药(03347)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供泰格医药(03347)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}